Futura Medical plc (AIM: FUM), a pharmaceutical company developing a
portfolio of innovative products for sexual health and pain relief, is
pleased to provide an update on good progress with its regulatory and
commercial activities for MED3000.
Liege, Belgium – November 3, 2022: medmix Drug Delivery (Haselmeier) and AARDEX Group announced today a collaboration, combining Haselmeier¥s D-Flex™ Logbook with AARDEX Groupís Medication Adherence software and hardware...
Read More
Basel, Switzerland, 06 September 2022 – On September 20, 2022,
Lonza will host a free virtual workshop on using genome editing
technologies for cell and gene therapies and drug discovery. The 3-hour
workshop brings together renowned genome editing experts from across
industry and academia and comprises four interactive speaker sessions
and a concluding panel discussion. The event is a chance for researchers
to engage directly with leading voices in the field, keep up to date
with the latest CRISPR research and application, and discover tips and
tricks for optimized CRISPR editing and screening.
